Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.01
-
Shares outstanding
-
27,407,170
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
12,826,719
-
Shares change
-
+189,489
-
Total reported value, excl. options
-
$221,801,858
-
Value change
-
+$1,817,935
-
Put/Call ratio
-
2.01%
-
Number of buys
-
43
-
Number of sells
-
-43
-
Price
-
$17.31
Significant Holders of ICAD, INC. - Common Stock, par value $0.01 (ICAD) as of Q2 2021
108 filings reported holding ICAD - ICAD, INC. - Common Stock, par value $0.01 as of Q2 2021.
ICAD, INC. - Common Stock, par value $0.01 (ICAD) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,826,719 shares
of 27,407,170 outstanding shares and own 46.8% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,379,590 shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (1,172,873 shares), VANGUARD GROUP INC (1,162,512 shares), Portolan Capital Management, LLC (810,818 shares), FEDERATED HERMES, INC. (707,053 shares), Parkman Healthcare Partners LLC (531,255 shares), G2 Investment Partners Management LLC (500,000 shares), KORNITZER CAPITAL MANAGEMENT INC /KS (409,090 shares), WELLINGTON MANAGEMENT GROUP LLP (388,795 shares), and GEODE CAPITAL MANAGEMENT, LLC (377,207 shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.